 |
John R. Seffrin, PhD
Chief Executive Officer |
John Seffrin has been CEO of the American Cancer Society since 1992, but his first encounter with this disease dates to his childhood. His grandmother, who was living with his family at the time, died of cancer when he was only 10 years old. He has since lost his mother to cancer, and his wife of 42 years, Carole, is a breast cancer survivor.
Dr. Seffrin has been on the frontlines of the war against cancer for many years, not only as CEO of the American Cancer Society, but also – for many years before that – as one of the Society’s roughly three million volunteers nationwide. Under his leadership, the Society has become the world’s largest voluntary health organization fighting cancer, with a billion dollars in resources to fund cancer research, advocacy, education, and service. During his tenure, Dr. Seffrin has made his organization’s voice heard in legislatures around this country and in forums worldwide. And he has not shied away from a fight, especially if the foe is the tobacco industry.
In the political realm, Dr. Seffrin has transformed the world’s largest voluntary cancer-fighting group into one of the world’s most progressive public health organizations. Under his leadership, the American Cancer Society has become a leading advocacy organization, educating lawmakers about health issues and holding them accountable to every American citizen touched by cancer.
Dr. Seffrin is active in numerous organizations. He is a past president of the Geneva-headquartered International Union Against Cancer, the first globally-oriented cancer non-governmental organization (NGO). He served as chairman of the board of Independent Sector, the largest coalition of nonprofit groups, and he helped to create the National Center for Tobacco-Free Kids, among his many collaborations and affiliations.
In 1999, Dr. Seffrin was selected to be a charter member of C-Change (formerly known as the National Dialogue on Cancer) Steering Committee, which is co-chaired by former President George H.W. Bush and former First Lady Barbara Bush. In 1997, he was appointed to the National Cancer Policy Board of the Institute of Medicine, and in 1999, he was appointed by Senator Dianne Feinstein to co-chair the National Cancer Legislation Advisory Committee. He current serves on the Advisory Committee to the Director of the US Centers for Disease Control and Prevention, a Secretary-level appointment.
Dr. Seffrin is a contributing author to more than one dozen books and has written more than 100 articles and other publications. He is an internationally esteemed speaker who has presented more than 100 invited lectures worldwide. Both Ball State University and Purdue University have bestowed honorary doctorates upon him in recognition of his more than three decades of leadership in the worldwide fight against cancer.
Prior to being named the American Cancer Society’s top staff executive, Dr. Seffrin served at Indiana University as Professor of Health Education and Chairman of the Department of Applied Health Science.
 |
Otis Webb Brawley, MD
Chief Medical Officer
|
As the chief medical officer of the American Cancer Society, Otis Webb Brawley, MD, is responsible for promoting the goals of cancer prevention, early detection, and quality treatment through cancer research and education. He champions efforts to decrease smoking, improve diet, detect cancer at the earliest stage, and provide the critical support cancer patients need. He also guides efforts to enhance and focus the research program, upgrade the Society’s advocacy capacity, and concentrate community cancer control efforts in areas where they will be most effective. Further, as an acknowledged global leader in the field of health disparities research, Dr. Brawley is a key leader in the Society’s work to eliminate disparities in access to quality cancer care.
A world renowned cancer expert and practicing oncologist, Dr. Brawley most recently served as professor of hematology, oncology, and epidemiology at Emory University, as medical director of the Georgia Cancer Center for Excellence at Grady Memorial Hospital in Atlanta, and as deputy director for cancer control at Winship Cancer Institute at Emory University. He has also previously served as a member of the Society’s Prostate Cancer Committee, co-chaired the Surgeon General’s Task Force on Cancer Health Disparities, and filled a variety of capacities at the National Cancer Institute (NCI), most recently serving as director of the Office of Special Populations Research.
Currently, Dr. Brawley serves as chair of the National Institutes of Health Consensus Panel on the Treatment of Sickle Cell Anemia and as a member of the Centers for Disease Control and Prevention Breast and Cervical Cancer Early Detection and Control Advisory Committee. Dr. Brawley is a graduate of University of Chicago, Pritzker School of Medicine. He completed his internship at University Hospital of Cleveland, Case-Western Reserve University, his residency at University Hospital of Cleveland, and his fellowship at the National Cancer Institute.
|
